help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on May 8, 2003, doi:10.1165/rcmb.2002-0243OC

Am. J. Respir. Cell Mol. Biol., Volume 29, Number 5, November 2003, 537-544

A more recent version of this article appeared on November 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0243OCv1
29/5/537    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolodsick, J. E
Right arrow Articles by Moore, B. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolodsick, J. E
Right arrow Articles by Moore, B. B

Submitted on November 12, 2002
Revised on May 7, 2003

PGE2 Inhibits Fibroblast to Myofibroblast Transition via EP2 Signaling and cAMP Elevation

Jill E Kolodsick1, Marc Peters-Golden1, Jose Larios1, Galen B Toews1, Victor J Thannickal1, and Bethany B Moore1*

1 Internal Medicine, University of Michigan, Ann Arbor, MI, USA

* To whom correspondence should be addressed. E-mail: bmoore{at}umich.edu.

Myofibroblasts, the hallmark of fibrotic disease, contribute to the pathology of fibrosis by secreting large amounts of extracellular matrix and contributing to alveolar contraction. Myofibroblasts are characterized by the expression of {alpha}-smooth muscle actin ({alpha}-SMA), a contractile protein normally associated with smooth muscle cells. Transforming growth factor-{beta}1 (TGF-{beta}1) is a well characterized pro-fibrotic cytokine that induces myofibroblast transformation both in vitro and in vivo. We report here that the lipid mediator prostaglandin E2 (PGE2) inhibits TGF-{beta}1-induced expression of {alpha}-SMA in primary fetal and adult lung fibroblasts. This inhibition of {alpha}-SMA expression is associated with a reduction in the expression of collagen I. Inhibitory actions of PGE2 are mediated via E prostanoid receptor 2 (EP2), but not EP3, signaling and increases in cAMP production. The inhibitory effects of PGE2 on TGF-{beta}1 induced {alpha}-SMA expression are mimicked by an EP2 selective agonist, butaprost, and by forskolin-induced direct activation of adenyl cyclase. An EP2 antagonist blocks the inhibitory effects of PGE2, and an EP3 agonist does not inhibit TGF-{beta}1-mediated increases in {alpha}-SMA expression. Our results demonstrate that PGE2 inhibits transition of fibroblasts to myofibroblasts by an EP2 receptor-activated pathway. Augmenting this pathway may serve as a potent anti-fibrotic therapeutic strategy.




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. Sandbo, S. Kregel, S. Taurin, S. Bhorade, and N. O. Dulin
Critical Role of Serum Response Factor in Pulmonary Myofibroblast Differentiation Induced by TGF-{beta}
Am. J. Respir. Cell Mol. Biol., September 1, 2009; 41(3): 332 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Failla, T. Genovese, E. Mazzon, M. Fruciano, E. Fagone, E. Gili, A. Barera, C. La Rosa, E. Conte, N. Crimi, et al.
16,16-Dimethyl Prostaglandin E2 Efficacy on Prevention and Protection from Bleomycin-Induced Lung Injury and Fibrosis
Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 50 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Togo, X. Liu, X. Wang, H. Sugiura, K. Kamio, S. Kawasaki, T. Kobayashi, R. F. Ertl, Y. Ahn, O. Holz, et al.
PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L959 - L969.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. Xing and J. A. Bonanno
Effect of cAMP on TGF{beta}1-Induced Corneal Keratocyte-Myofibroblast Transformation
Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 626 - 633.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G. J. Sturm, I. Th. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
J. Immunol., November 15, 2008; 181(10): 7273 - 7283.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Ding, C. L. Gladson, H. Wu, H. Hayasaka, and M. A. Olman
Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner
J. Biol. Chem., October 3, 2008; 283(40): 26839 - 26849.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. K. Huang, S. H. Wettlaufer, J. Chung, and M. Peters-Golden
Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 482 - 489.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Xu, K. Ravid, and B. D. Smith
Major Histocompatibility Class II Transactivator Expression in Smooth Muscle Cells from A2b Adenosine Receptor Knock-out Mice: CROSS-TALK BETWEEN THE ADENOSINE AND INTERFERON-{gamma} SIGNALING
J. Biol. Chem., May 23, 2008; 283(21): 14213 - 14220.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. H. Lee, Y. J. Suzuki, A. J. Griffin, and R. M. Day
Hepatocyte growth factor regulates cyclooxygenase-2 expression via {beta}-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L778 - L786.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. F. Muro, F. A. Moretti, B. B. Moore, M. Yan, R. G. Atrasz, C. A. Wilke, K. R. Flaherty, F. J. Martinez, J. L. Tsui, D. Sheppard, et al.
An Essential Role for Fibronectin Extra Type III Domain A in Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 638 - 645.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
K. Gronert
Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege
Mol. Interv., February 1, 2008; 8(1): 28 - 35.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. E. White, Q. Ding, B. B. Moore, M. Peters-Golden, L. B. Ware, M. A. Matthay, and M. A. Olman
Prostaglandin E2 Mediates IL-1 -Related Fibroblast Mitogenic Effects in Acute Lung Injury through Differential Utilization of Prostanoid Receptors
J. Immunol., January 1, 2008; 180(1): 637 - 646.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. K. Huang, S. H. Wettlaufer, C. M. Hogaboam, K. R. Flaherty, F. J. Martinez, J. L. Myers, T. V. Colby, W. D. Travis, G. B. Toews, and M. Peters-Golden
Variable Prostaglandin E2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 66 - 74.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Peres, D. M. Aronoff, C. H. Serezani, N. Flamand, L. H. Faccioli, and M. Peters-Golden
Specific Leukotriene Receptors Couple to Distinct G Proteins to Effect Stimulation of Alveolar Macrophage Host Defense Functions
J. Immunol., October 15, 2007; 179(8): 5454 - 5461.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Thomas, M. Peters-Golden, E. S. White, V. J. Thannickal, and B. B. Moore
PGE2 inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L417 - L428.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. Aronoff, C. M. Peres, C. H. Serezani, M. N. Ballinger, J. K. Carstens, N. Coleman, B. B. Moore, R. S. Peebles, L. H. Faccioli, and M. Peters-Golden
Synthetic Prostacyclin Analogs Differentially Regulate Macrophage Function via Distinct Analog-Receptor Binding Specificities
J. Immunol., February 1, 2007; 178(3): 1628 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden
Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L405 - L413.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Zhang, M.-H. Wang, Z. Dong, and T. Yang
Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1323 - F1331.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. R. Hill, A. Papafili, H. Booth, P. Lawson, M. Hubner, H. Beynon, C. Read, G. Lindahl, R. P. Marshall, R. J. McAnulty, et al.
Functional Prostaglandin-Endoperoxide Synthase 2 Polymorphism Predicts Poor Outcome in Sarcoidosis
Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. P. Meng, S. Ceryak, Z. Aratsu, L. Jones, L. Epstein, and B. Bouscarel
Biphasic regulation by bile acids of dermal fibroblast proliferation through regulation of cAMP production and COX-2 expression level
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C546 - C554.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. B. Moore, L. Murray, A. Das, C. A. Wilke, A. B. Herrygers, and G. B. Toews
The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 175 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. K. Lovgren, L. A. Jania, J. M. Hartney, K. K. Parsons, L. P. Audoly, G. A. FitzGerald, S. L. Tilley, and B. H. Koller
COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L144 - L156.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Boxall, S. T. Holgate, and D. E. Davies
The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma
Eur. Respir. J., January 1, 2006; 27(1): 208 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Murakami, N. Nagaya, T. Itoh, M. Kataoka, T. Iwase, T. Horio, Y. Miyahara, Y. Sakai, K. Kangawa, and H. Kimura
Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L59 - L65.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X. Liu, S. Q. Sun, and R. S. Ostrom
Fibrotic Lung Fibroblasts Show Blunted Inhibition by cAMP Due to Deficient cAMP Response Element-Binding Protein Phosphorylation
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 678 - 687.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha, and A.M. Kuijpers-Jagtman
Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair
Journal of Dental Research, October 1, 2005; 84(10): 871 - 880.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. M. A. O'Reilly, R. P. Phipps, T. H. Thatcher, B. A. Graf, J. Van Kirk, and P. J. Sime
Crystalline and amorphous silica differentially regulate the cyclooxygenase-prostaglandin pathway in pulmonary fibroblasts: implications for pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1010 - L1016.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. B. Moore, M. N. Ballinger, E. S. White, M. E. Green, A. B. Herrygers, C. A. Wilke, G. B. Toews, and M. Peters-Golden
Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2
J. Immunol., May 1, 2005; 174(9): 5644 - 5649.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Sokolova, Z. Grishina, F. Buhling, T. Welte, and G. Reiser
Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L793 - L802.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. B. Moore, J. E. Kolodsick, V. J. Thannickal, K. Cooke, T. A. Moore, C. Hogaboam, C. A. Wilke, and G. B. Toews
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Am. J. Pathol., March 1, 2005; 166(3): 675 - 684.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Tsuruda, J. Kato, K. Hatakeyama, H. Masuyama, Y.-N. Cao, T. Imamura, K. Kitamura, Y. Asada, and T. Eto
Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats
Cardiovasc Res, March 1, 2005; 65(4): 921 - 929.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. S. White, R. G. Atrasz, E. G. Dickie, D. M. Aronoff, V. Stambolic, T. W. Mak, B. B. Moore, and M. Peters-Golden
Prostaglandin E2 Inhibits Fibroblast Migration by E-Prostanoid 2 Receptor-Mediated Increase in PTEN Activity
Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 135 - 141.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. Aronoff, C. Canetti, C. H. Serezani, M. Luo, and M. Peters-Golden
Cutting Edge: Macrophage Inhibition by Cyclic AMP (cAMP): Differential Roles of Protein Kinase A and Exchange Protein Directly Activated by cAMP-1
J. Immunol., January 15, 2005; 174(2): 595 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. S. Swaney, D. M. Roth, E. R. Olson, J. E. Naugle, J. G. Meszaros, and P. A. Insel
Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase
PNAS, January 11, 2005; 102(2): 437 - 442.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. J. Hodges, R. G. Jenkins, C. P.D. Wheeler-Jones, D. M. Copeman, S. E. Bottoms, G. J. Bellingan, C. B. Nanthakumar, G. J. Laurent, S. L. Hart, M. L. Foster, et al.
Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production
Am. J. Pathol., November 1, 2004; 165(5): 1663 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Peters-Golden
The Alveolar Macrophage: The Forgotten Cell in Asthma
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 3 - 7.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. Aronoff, C. Canetti, and M. Peters-Golden
Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP
J. Immunol., July 1, 2004; 173(1): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
X. Liu, R. S. Ostrom, and P. A. Insel
cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1089 - C1099.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society. 		  CCM abstracts